Saol Therapeutics

CYTOGAM

  1. Home
  2.  / 
  3. J Code
  4.  / CYTOGAM – J0850

Manufacturer:

Saol Therapeutics

Name:

CYTOGAM

HCPCS Code Descriptor:

Injection, cytomegalovirus immune globulin intravenous (human), per vial

Category:

J Code

HCPCS:

J0850

NDC(s):

70257-0532-51

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

CYTOGAM is an Oncology drug manufactured by Saol Therapeutics and administered via the Intravenous route of administration. The J Code: J0850 is aligned to the drug CYTOGAM.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/82

HCPCS Effective Date:

1/1/97

HCPCS Short Description:

Cytomegalovirus imm iv /vial

Billing and Coding Guide:

https://cytogam.com/ordering-and-reimbursement/

Patient Assistance:

Not Found